Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Interest Coverage Ratio (2016 - 2017)

Heron Therapeutics' Interest Coverage Ratio history spans 4 years, with the latest figure at 11.48 for Q3 2017.

  • For Q3 2017, Interest Coverage Ratio changed N/A year-over-year to 11.48; the TTM value through Jun 2018 reached 94.66, down 45.44%, while the annual FY2025 figure was 0.26, 86.17% up from the prior year.
  • Interest Coverage Ratio reached 11.48 in Q3 2017 per HRTX's latest filing, up from 11.68 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 11.48 in Q3 2017 to a low of 74.19 in Q2 2013.
  • Average Interest Coverage Ratio over 3 years is 42.66, with a median of 60.59 recorded in 2013.
  • The largest YoY upside for Interest Coverage Ratio was 168.72% in 2013 against a maximum downside of 168.72% in 2013.
  • A 3-year view of Interest Coverage Ratio shows it stood at 60.59 in 2013, then dropped by 4.89% to 63.56 in 2016, then surged by 81.94% to 11.48 in 2017.
  • Per Business Quant, the three most recent readings for HRTX's Interest Coverage Ratio are 11.48 (Q3 2017), 11.68 (Q2 2017), and 13.69 (Q1 2017).